WemedooWemedoo AG provides a unified clinical trial software platform called oomnia that replaces eight disconnected tools (EDC, CTMS, RTSM, eTMF, ePRO, eSource, eConsent, and eCOA) with a single AI-powered ecosystem. The Swiss health tech company serves sponsors, CROs, biotech organizations, and academic institutions, aiming to accelerate trial setup by up to 83% and increase operational efficiency by 50%.